Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
331
Gastroenterology. 2008. Vol. 135. P. 1953-1960.
Bolland M.J., Leung W., Tai V. et al. Calcium intake and risk of fracture: systematic review // BMJ. 2015.
Vol. 351. Article ID h4580.
Bolton J.M., Morin S.N., Majumdar S.R. et al. Association of mental disorders and related medication
use with risk for major osteoporotic fractures // JAMA Psychiatry.
2017. Vol. 74, N. 6. P. 641-648.
Bonello L., Laine M., Lemesle G. et al. Meta-analysis of potent P2Y
12
-ADP receptor antagonist therapy
compared to clopidogrel therapy in acute coronary syndrome patients with chronic kidney // Thromb.
Haemost. 2018. Vol. 118, N. 10. P. 1839-1846.
Bont J., Hak E., Birkhoff C.E. et al. Is co-morbidity taken into account in the antibiotic management of
elderly patients with acute bronchitis and COPD exacerbations? // Fam. Pract. 2007. Vol. 24, N. 4. P.
317-322.
Bot M., Pouwer F., Zuidersma M. et al. Association of coexisting diabetes and depression with mortality
after myocardial infarction // Diabetes Care. 2012. Vol. 35,
N. 3. P. 503-509.
Botha T.C., Pilcher G.J., Wolmarans K. et al. Statins and other lipid-lowering therapy and pregnancy
outcomes in homozygous familial hypercholesterolaemia: a retrospective review of 39 pregnancies //
Atherosclerosis. 2018. Vol. 277. P. 502-507.
Boussageon R., Bejan-Angoulvant T., Saadatian-Elahi M. et al. Effect of intensive glucose lowering
treatment on all-cause mortality, cardiovascular death, and microvas-cular events in type 2 diabetes:
meta-analysis of randomised controlled trials // BMJ. 2011. Vol. 343. Article ID d4169.
Boyd C.M., Darer J., Boult C. et al. Clinical practice guidelines and quality of care for older patients with
multiple comorbid diseases: implications for pay for performance // JAMA. 2005. Vol. 294, N. 6. P. 716-
724.
Brahm N.C., Kelly-Rehm M.C. Antidepressant-mediated gastroesophageal reflux
disease // Consult. Pharm. 2011. Vol. 26, N. 4. P. 274-278.
Braithwaite R.S., Concato J., Chang C.C. et al. A framework for tailoring clinical guidelines to
comorbidity at the point of care // Arch. Intern. Med. 2007. Vol. 167,
N. 21. P. 2361-2365.
Bramness J.G., Skurtveit S., Neutel C.I. et al. Minor increase in risk of road traffic accidents after
prescriptions of antidepressants: a study of population registry data in
Norway // J. Clin. Psychiatry. 2008. Vol. 69, N. 7. P. 1099-1103.
Brenner and Rector's the Kidney. 9
th
ed. Philadelphia, Pa : Saunders; Elsevier,
2012. 2448 p.
Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in Pregnancy and Lactation: a Reference Guide to Fetal and
Neonatal Risk. 9
th
ed. Lippincott Williams and Wilkins, 2011. 1728 p.
Broch K., Urheim S., Lonnebakken M.T. et al. Controlled release metoprolol for aortic regurgitation: a
randomised clinical trial // Heart. 2016. Vol. 102, N. 3.
Источник KingMed.info
332
P. 191-197.
Brodsky S.V., Nadasdy T., Rovin B.H. et al. Warfarin-related nephropathy occurs in patients with and
without chronic kidney disease and is associated with an increased mortality rate // Kidney Int. 2011.
Vol. 80, N. 2. P. 181-189.
Broers C., Tack J., Pauwels A. Review article: gastro-oesophageal reflux disease in asthma and chronic
obstructive pulmonary disease // Aliment. Pharmacol. Ther. 2018.
Vol. 47. P. 176-191.
Bronskill S., Campitelli M., Iaboni A. et al. Low-dose trazodone, benzodiazepines, and fall-related
injuries in nursing homes: a matched-cohort study // J. Am. Geriatr.
Soc. 2018. Vol. 10. P. 1963-1971.
Brouwer I.A., Raitt M.H., Dullemeij er C. et al. Effect of fish oil on ventricular tachyarrhythmia in three
studies in patients with implantable cardioverter defibrillators // Eur. Heart J. 2009. Vol. 30, N. 7. P. 820-
826.
Brown H.K., Ray J.G., Wilton A.S. et al. Association Between Serotonergic Antidepressant Use During
Pregnancy and Autism Spectrum Disorder in Children //
JAMA. 2017. Vol. 317, N. 15. P. 1544-1552.
Bruere H., Fauchier L., Bernard Brunet A. et al. History of thyroid disorders in relation to clinical
outcomes in atrial fibrillation // Am. J. Med. 2015. Vol. 128. P. 30-37.
Buganza-Torio E., Mitchell N., Abraldes J.G. et al. Depression in cirrhosis - a prospective evaluation of
the prevalence, predictors and development of a screening nomogram // Aliment. Pharmacol. Ther.
2019. Vol. 49. P. 194-201.
Bulugahapitiya U., Siyambalapitiya S., Sithole J., Idris I. Is diabetes a coronary risk equivalent?
Systematic review and meta-analysis // Diabet. Med. 2009. Vol. 26, N. 2.
P. 142-148.
Burashnikov A., Sicouri S., Di Diego J.M. et al. Synergistic effect of the combination of ranolazine and
dronedarone to suppress atrial fibrillation // J. Am. Coll. Cardiol. 2010. Vol. 56, N. 15. P. 1216-1224.
Burchill L.J., Lameijer H., Roos-Hesselink J.W. et al. Pregnancy risks in women with pre-existing coronary
artery disease, or following acute coronary syndrome // Heart. 2015. Vol. 101, N. 7. P. 525-529.
Butt D.A., Mamdani M., Austin P.C. et al. The risk of hip fracture after initiating antihypertensive drugs
in the elderly // Arch. Intern. Med. 2012. Vol. 172, N. 22.
P. 1739-1744.
Butt J.H., Xian Y., Peterson E.D. et al. Long-term thromboembolic risk in patients with postoperative
atrial fibrillation after coronary artery bypass graft surgery and patients with nonvalvular atrial
fibrillation // JAMA Cardiol. 2018. Vol. 3. P. 417-424.
Butt A., Yan P., Shuaib A. et al. Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a
Reduced Risk of Cardiovascular // Dis. Events. Gastroenterol. 2019. Vol. 4. P. 987-996.
Источник KingMed.info
333
Cadrin-Tourigny J., Wyse D.G., Roy D. et al. Efficacy of amiodarone in patients with atrial fibrillation with
and without left ventricular dysfunction: apooled analysis of AFFIRM and AF-CHF trials // J. Cardiovasc.
Electrophysiol. 2014. Vol. 25, N. 12.
P. 1306-1313.
Cahill L.E., Jensen M.K., Chiuve S.E. et al. The risk of coronary heart disease associated with glycosylated
hemoglobin of 6.5% or greater is pronounced in the haptoglobin 2-2 genotype // J. Am. Coll. Cardiol.
2015. Vol. 66, N. 16. P. 1791-1799.
Cai X., Yang W., Gao X. et al. The association between the dosage of SGLT2 inhibitor and weight
reduction in type 2 diabetes patients: ameta-analysis // Obesity (Silver Spring). 2018. Vol. 26, N. 1. P.
70-80.
Cantarovich F., Rangoonwala B., Lorenz H. et al. High-dose furosemide for established ARF: a
prospective, randomized, double-blind, placebo-controlled,
multicenter trial // Am. J. Kidney Dis. 2004. Vol. 44, N. 3. P. 402-409.
Cappuccio F.P., Meilahn E., Zmuda J.M. et al. High blood pressure and bone-mineral loss in elderly
white women: a prospective study // Lancet. 1999. Vol. 354,
N. 9183. P. 971-975.
Cardoso R.N., Benjo A.M., DiNicolantonio J.J. et al. Incidence of cardiovascular events and
gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an
updated meta-analysis // Open Heart. 2015. Vol. 2, N. 1.
Article ID e000248.
Carles G., Helou J., Dallah F. et al. [Use of injectable urapidil in pregnancy-induced hypertension and
preeclampsia // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2012. Vol. 41, N. 7. P. 645-649.
Carmo J., Moscoso Costa F., Ferreira J., Mendes M. Dabigatran in real-world atrial fibrillatioN. Meta-
analysis of observational comparison studies with vitamin K antagonists // Thromb. Haemost. 2016.
Vol. 116, N. 4. P. 754-763.
Caspi D., Lubart E., Graff E. et al. The effect of mini-dose aspirin on renal function and uric acid handling
in elderly patients // Arthritis Rheum. 2000. Vol. 43. P. 103-108.
Castagno D., Baird-Gunning J., Jhund P.S. et al. Intensive glycemic control has no impact on the risk of
heart failure in type 2 diabetic patients: evidence from a 37 229 patient meta-analysis // Am. Heart J.
2011. Vol. 162, N. 5. P. 938-948.
Castellsague J., Riera-Guardia N., Calingaert B. et al. Individual NSAIDs and upper gastrointestinal
complications: a systematic review and meta-analysis of observational studies (the SOS Project) // Drug
Saf. 2012. Vol. 35, N. 12. P. 1127-1146.
Castro V.M., Clements C.C., Murphy S.N. et al. QT interval and antidepressant use: a cross sectional
study of electronic health records // BMJ. 2013. Vol. 346. Article
ID f288.
Cates C.J., Cates M.J., Lasserson T.J. Regular treatment with formoterol for chronic asthma: serious
adverse events // Cochrane Database Syst. Rev. 2008. Vol. 4.
Источник KingMed.info
334
Caton A.R., Bell E.M., Druschel C.M. et al. Antihypertensive medication use during pregnancy and the
risk of cardiovascular malformations // Hypertension. 2009.
Vol. 54. P. 63-70.
Caughey G.E., Vitry A.I., Gilbert A.L., Roughead E.E. Prevalence of comorbidity of chronic diseases in
Australia // BMC Public Health. 2008. Vol. 8. P. 221.
Cavallari I., Patti G. Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic
therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention // Am. J.
Cardiol. 2018. Vol. 121, N. 6. P. 718-724.
Cederberg H., Stančáková A., Yaluri N. et al. Increased risk of diabetes with statin treatment is
associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the
METSIM cohort // Diabetologia. 2015. Vol. 58. P. 1109-1117.
Celeng C., Maurovich-Horvat P., Ghoshhajra B.B. et al. Prognostic value of coronary computed
tomography angiography in patients with diabetes: ameta-analysis // Diabetes Care. 2016. Vol. 39, N. 7.
P. 1274-1280.
Chan K.K., Lai P., Wright J.M. First-line beta-blockers versus other antihypertensive medications for
chronic type B aortic dissection // Cochrane Database Syst. Rev. 2014.
Vol. 2. CD010426.
Chan K.Y., Li C.W., Wong H. et al. Use of sertraline for antihistamine-refractory uremic pruritus in renal
palliative care patients // J. Palliat. Med. 2013. Vol. 16, N. 8.
P. 966-970.
Chan P.H., Hai J., Yeung C.Y., Lip G.Y. et al. Benefit of anticoagulation therapy in hyperthyroidism-
related atrial fibrillation // Clin. Cardiol. 2015. Vol. 38, N. 8.
P. 476-482.
Chan W.-L., Yang K.-P., Chao T.-F. et al. The association of asthma and atrial fibrillation - a nationwide
population-based nested case-control study // Int. J. Cardiol. 2014. Vol. 176, N. 2. P. 464-469.
Chan W.W., Chiou E., Obstein K.L. et al. The efficacy of proton pump inhibitors for the treatment of
asthma in adults: ameta-analysis // Arch. Intern. Med. 2011. Vol. 171, N. 7. P. 620-629.
Chandra D., Gupta A., Strollo P.J. et al. Airflow limitation and endothelial dysfunctioN. unrelated and
independent predictors of atherosclerosis // Am. J. Crit. Care Med. 2016. Vol. 194, N. 1. P. 38-47.
Chang C.C., Chiou C.S., Lin H.L. et al. Increased risk of acute pancreatitis in patients with rheumatoid
arthritis: apopulation-based cohort study // PLoS One. 2015. Vol. 10, N. 8. Article ID e0135187.
Chang C.H., Chang Y.C., Wu L.C. et al. Different angiotensin receptor blockers and incidence of
diabetes: a nationwide population-based cohort study // Cardiovasc.
Diabetol. 2014. Vol. 13. P. 91.
Chang C.M., Wu E.C., Chen C.Y. et al. Psychotropic drugs risk of motor vehicle accidents: a population-
based case-control study // Br. J. Clin. Pharmacol. 2013.
Vol. 75, N. 4. P. 1125-1133.
Источник KingMed.info
335
Chang S.H., Wu L.S., Chiou M.J. et al. Association of metformin with lower atrial fibrillation risk among
patients with type 2 diabetes mellitus: a population-Based dynamic cohort and in vitro studies //
Cardiovasc. Diabetol. 2014. Vol. 13, N. 1. P. 123.
Chang T.I., Montez-Rath M.E., Tsai T.T. et al. Drug-eluting versus bare-metal stents during PCI in
patients with end-stage renal disease on dialysis // J. Am. Coll.
Cardiol. 2016. Vol. 67, N. 12. P. 1459-1469.
Chao C.T., Wang J., Huang J.W. et al. Acarbose use and liver injury in diabetic patients with severe renal
insufficiency and hepatic diseases: apropensity score-matched cohort study // Front. Pharmacol. 2018.
Vol. 9. P. 860.
Chao T.-F., Liu C.-J., Liao J.-N. et al. Use of oral anticoagulants for stroke prevention in patients with
atrial fibrillation who have a history of intracranial hemorrhage // Circulation. 2016. Vol. 133, N. 16. P.
1540-1547.
Charles-Schoeman C., Wicker P., Gonzalez-Gay M.A. et al. Cardiovascular safety findings in patients
with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor // Semin. Arthritis
Rheum. 2016. Vol. 46, N. 3. P. 261-271.
Charytan D.M., Desai M., Mathur M. et al. Reduced risk of myocardial infarct and revascularization
following coronary artery bypass grafting compared with percutaneous coronary intervention in
patients with chronic kidney disease // Kidney Int. 2016. Vol. 90, N. 2. P. 411-421.
Chatterjee S., Bavishi C., Sardar P. et al. Meta-analysis of left ventricular hypertrophy and sustained
arrhythmias // Am. J. Cardiol. 2014. Vol. 114. P. 1049-1052.
Chen CH, Lin CL, Kao CH, et al. Association between gastroesophageal reflux disease and coronary
heart disease: A nationwide population-based analysis. Medicine
(Baltimore). 2016;95(27):e4089.
Chen H.P., Shieh J.J., Chang C.C. et al. Metformin decreases hepatocellular carcinoma risk in a dose-
dependent manner: population-based and in vitro studies // Gut.
2013. Vol. 62, N. 4. P. 606-615.
Chen J., Radford M.J., Wang Y. et al. Effectiveness of beta-Blocker therapy after acute myocardial
infarction in elderly patients with chronic obstructive pulmonary disease or asthma // J. Am. Coll.
Cardiol. 2001. Vol. 37, N. 7. P. 1950-1956.
Chen J.-J., Lin L.-Y., Yang Y.-H. et al. On pump versus off pump coronary artery bypass grafting in
patients with end-stage renal disease and coronary artery disease - a nation-wide, propensity score
matched database analyses // Int. J. Cardiol. 2017.
Vol. 227. P. 529-534.
Chen K.P., Cavender S., Lee J. et al. Peripheral edema, central venous pressure, and risk of AKI in critical
illness // Clin. J. Am. Soc. Nephrol. 2016. Vol. 11, N. 4. P. 602-608.
Chen V.C., Ng M.H., Chiu W.C. et al. Effects of selective serotonin reuptake inhibitors on glaucoma: a
nationwide population-based study // PLoS One. 2017. Vol. 12,
N. 3. Article ID e0173005.
Источник KingMed.info
336
Chen Y.H., Chiang M.H., Liu J.S. et al. Thiazolidinediones and risk of long-term dialysis in diabetic
patients with advanced chronic kidney disease: anationwide cohort study // PLoS One. 2015. Vol. 10, N.
6. Article ID e0129922.
Cheng J., Zhang W., Zhang X. et al. Effect of ACE inhibitors and angiotensin II receptor blockers on all-
cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus:
ameta-analysis // JAMA Intern. Med. 2014.
Vol. 174. P. 773-785.
Cheong E.J.Y., Goh J.J.N., Hong Y., Kojodjojo P. et al. Rivaroxaban with and without amiodarone in renal
impairment // J. Am. Coll. Cardiol. 2018. Vol. 71, N. 12.
P. 1395-1397.
Cherney D.Z.I., Cooper M.E., Tikkanen I. et al. Pooled analysis of Phase III trials indicate contrasting
influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin
// Kidney Int. 2018. Vol. 93, N. 1. P. 231-244.
Cheungpasitporn W., Thongprayoon C., Wijarnpreecha K. et al. Decline in prevalence and risk of
helicobacter pylori in kidney transplant recipients: A systematic review and meta-analysis // J. Evid.
Based. Med. 2017. Vol. 10, N. 3. P. 171-176.
Chin C.Y., Matsumura M., Maehara A. et al. Coronary plaque characteristics in hemodialysis-dependent
patients as assessed by optical coherence tomography // Am.
J. Cardiol. 2017. Vol. 119, N. 9.P. 1313-1319.
Chockalingam P., Crotti L., Girardengo G. et al. Not all beta-blockers are equal in the management of
long QT syndrome types 1 and 2: higher recurrence of events under
metoprolol // J. Am. Coll. Cardiol. 2012. Vol. 60, N. 20. P. 2092-2099.
Choi H.K., Soriano L.C., Zhang Y., Rodriguez L.A. Antihypertensive drugs and risk of incident gout
among patients with hypertension: population based case-control study // BMJ. 2012. Vol. 344. Article
ID d8190.
Choi J., Choi C., Hwang S. et al. Effect of pitavastatin compared with atorvastatin and rosuvastatin on
new-onset diabetes mellitus in patients with acute myocardial Infarction // Am. J. Cardiol. 2018. Vol. 6.
P. 922-928.
Choi Y.H., Chung J.H., Bae S.W. et al. Severe coronary artery spasm can be associated with
hyperthyroidism // Coron. Artery. Dis. 2005. Vol. 16, N. 3. P. 135-139.
Chokesuwattanaskul R., Thongprayoon C., Tanawuttiwat T. et al. Safety and efficacy of apixaban versus
warfarin in patients with end-stage renal disease: meta-analysis //
Pacing Clin. Electrophysiol. 2018. Vol. 41. P. 627-634.
Chorin E., Hu D., Antzelevitch C. et al. Ranolazine for congenital long-QT syndrome type III:
experimental and long-term clinical data // Circ. Arrhythm.
Electrophysiol. 2016. Vol. 9. e004370.
Choudhry N.K., Fischer M.A., Avorn J. et al. The implications of therapeutic complexity on adherence to
cardiovascular medications // Arch. Intern. Med. 2011. Vol. 171,
Источник KingMed.info
337
N. 9. P. 814-822.
Chow E., Bernjak A., Williams S. et al. Risk of cardiac arrhythmias during hypoglycemia in patients with
type 2 diabetes and cardiovascular risk // Diabetes. 2014. Vol. 63,
N. 5. P. 1738-1747.
Christensen S., Thomsen R.W., Torring M.L. et al. Impact of COPD on outcome among patients with
complicated peptic ulcer // Chest. 2008. Vol. 133. P. 1360-1366.
Christiansen C.F., Christensen S., Mehnert F. et al. Glucocorticoid use and risk of atrial fibrillation or
flutter: apopulation-based, case-control study // Arch. Intern. Med.
2009. Vol. 169, N. 18. P. 1677-1683.
Chugh A., Makkar A., Yen Ho S. et al. Manifestations of coronary arterial injury during catheter ablation
of atrial fibrillation and related arrhythmias. Heart Rhythm.
2013. Vol. 10, N. 11. P. 1638-1645.
Chung M., Tang A.M., Fu Z. et al. Calcium intake and cardiovascular disease risk: an updated systematic
review and meta-analysis // Ann. Intern. Med. 2016. Vol. 165,
N. 12. P. 856-866.
Clair C., Rigotti N.A., Porneala B. et al. Association of smoking cessation and weight change with
cardiovascular disease among adults with and without diabetes //
JAMA. 2013. Vol. 309. P. 1014-1021.
Clark A.L., Chyu J., Horwich T.B. The obesity paradox in men versus women with
systolic heart failure // Am. J. Cardiol. 2012. Vol. 110, N. 1. P. 77-82.
Coca S.G., Ismail-Beigi F., Haq N. et al. Role of intensive glucose control in development of renal end
points in type 2 diabetes mellitussystematic review and meta-analysis intensive glucose control in type
2 diabetes // Arch. Intern. Med. 2012.
Vol. 172, N. 10. P. 761-769.
Cohen A.D., Kagen M., Friger M., Halevy S. Calcium channel blockers intake and psoriasis: a case-
control study // Acta. Derm. Venereol. 2001. Vol. 81, N. 5. P. 347-349.
Cohen L.S., Viguera A.C., McInerney K.A. et al. Reproductive safety of second-generation antipsychotics:
current data from the Massachusetts General Hospital National Pregnancy Registry for Atypical
Antipsychotics // Am. J. Psychiatry. 2016.
Vol. 173, N. 3. P. 263-270.
Collet T., Gussekloo J., Bauer D.C. et al. Subclinical hyperthyroidism and the risk of coronary heart
disease and mortality // Arch. Intern. Med. 2012. Vol. 172, N. 10.
P. 799-809.
Cooper S.J., Reynolds G.P., Barnes T. et al. BAP guidelines on the management of weight gain,
metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug
treatment // J. Psychopharmacol. 2016. Vol. 30, N. 8.
P. 717-748.
Источник KingMed.info
338
Cotté F.-E., Chaize G., Gaudin A.-F. et al. Burden of stroke and other cardiovascular complications in
patients with atrial fibrillation hospitalized in France // Europace. 2016. Vol. 18, N. 4. P. 501-507.
Coupland C., Hill T., Morriss R., Moore M. et al. Antidepressant use and risk of cardiovascular outcomes
in people aged 20 to 64: cohort study using primary care database // BMJ. 2016. Vol. 352. Article ID
i1350.
Coutinho T., Goel K., Correa de Sa D. et al. Central obesity and survival in subjects with coronary artery
disease: asystematic review of the literature and collaborative analysis with individual subject data // J.
Am. Coll. Cardiol. 2011. Vol. 57, N. 19.
P. 1877-1886.
Crisafulli E., Costi S., Luppi F. et al. Role of comorbidities in a cohort of patients with COPD undergoing
pulmonary rehabilitation // Thorax. 2008. Vol. 63, N. 6.
P. 487-492.
Cumming R.G., Le Couteur D.G. Benzodiazepines and risk of hip fractures in older people: a review of
the evidence // CNS Drugs. 2003. Vol. 17, N. 11. P. 825-837.
Curtis J.P., Selter J.G., Wang Y. et al. The obesity paradox: body mass index and outcomes in patients
with heart failure // Arch. Intern. Med. 2005. Vol. 165. P. 55-61.
Cusi K., Orsak B., Bril F. et al. Long-term pioglitazone treatment for patients with nonalcoholic
steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial // Ann. Intern. Med.
2016. Vol. 165. P. 305-315.
D'Souza R., Ostro J., Shah P.S. et al. Anticoagulation for pregnant women with mechanical heart valves:
a systematic review and meta-analysis // Eur. Heart J. 2017.
Vol. 38, N. 19. P. 1509-1516.
Da Dalt L., Ruscica M., Bonacina F. et al. PCSK9 deficiency reduces insulin secretion and promotes
glucose intolerance: the role of the low-density lipoprotein receptor // Eur. Heart J. 2019. Vol. 4. P. 357-
368.
Dagres N., Varounis C., Gaspar T. et al. Catheter ablation for atrial fibrillation in patients with left
ventricular systolic dysfunction. A systematic review and meta-analy-
sis // J. Card. Fail. 2011. Vol. 17, N. 11. P. 964-970.
Dahal K., Kunwar S., Rijal J., Schulman P. et al. Stroke, major bleeding, and mortality outcomes in
warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational
studies // Chest. 2016. Vol. 149, N. 4. P. 951-959.
Dai B., Liu Y., Fu L. et al. Effect of theophylline on prevention of contrast-induced acute kidney injury:
ameta-analysis of randomized controlled trials // Am. J. Kidney
Dis. 2012. Vol. 60, N. 3. P. 360-370.
Dam G., Vilstrup H., Andersen P.K. et al. Effect of proton pump inhibitors on the risk and prognosis of
infections in patients with cirrhosis and ascites // Liver Int. 2019.
Vol. 39, N. 3. P. 514-521.
Источник KingMed.info
339
Danziger J., William J.H., Scott D.J. et al. Proton-pump inhibitor use is associated with low serum
magnesium concentrations // Kidney Int. 2013. Vol. 83, N. 4. P. 692-699.
Davidson B.L., Verheijen S., Lensing A.A. et al. Bleeding risk of patients with acute venous
thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin // JAMA Intern. Med. 2014.
Vol. 174, N. 6. P. 947-953.
Dawwas M.F., Davies S.E., Griffiths W.J.H. et al. Prevalence and risk factors for liver involvement in
individuals with PiZZ-related lung disease // Am. J. Respir. Crit.
Care. Med. 2013. Vol. 187, N. 5. P. 502-508.
De Carvalho L.S.F., Campos A.M., Sposito A.C. et al. Proprotein convertase aubtilisin/kexintype 9
(PCSK9) inhibitors and incident type 2 diabetes: asystematic review and meta-analysis with over 96 000
patient-years // Diabetes Care. 2018. Vol. 41,
N. 2. P. 364-367.
De Moraes C. Hypertension overtreatment may speed vision loss in glaucoma // American Glaucoma
Society (AGS) 23
rd
Annual Meeting. San Francisco, 2013.
De Souza M.V.L., de Fátima dos Santos Teixeira P., Vaisman M., Xavier S.S. Is CHA
2
DS
2
-VASc appropriate
for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal
echocardiography evaluation // Int. J.
Cardiol. 2017. Vol. 228. P. 919-925.
Dean T.E., Cheryl A.S., Scot H.S. et al. Recurrent community-acquired pneumonia in patients starting
acid-suppressing drugs // Am. J. Med. 2010. Vol. 123, N. 1. P. 47-53.
DeCarolis D.D., Thorson J.G., Clairmont M.A. et al. Enoxaparin outcomes in patients with moderate renal
impairment // Arch. Intern. Med. 2012. Vol. 172, N. 22.
P. 1713-1718.
Deftereos S., Giannopoulos G., Kossyvakis C. et al. Effectiveness of moxonidine to reduce atrial
fibrillation burden in hypertensive patients // Am. J. Cardiol. 2013.
Vol. 112, N. 5. P. 684-687.
Delling L., Karason K., Olbers T. et al. Feasibility of bariatric surgery as a strategy for secondary
prevention in cardiovascular disease: a report from the Swedish obese subjects trial // J. Obes. 2010.
Vol. 2010. Article ID 102341.
Dennis J., Henley W., Weedon M. et al. Sex and BMI alter the benefits and risks of sulfonylureas and
thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and
individual trial data // Diabetes Care. 2018.
Vol. 9. P. 1844-1853.
Derosa G., Maffioli P., Reiner Z. et al. Impact of statin therapy on plasma uric acid concentrations:
asystematic review and meta-analysis // Drugs. 2016. Vol. 76, N. 9.
P. 947-956.
Источник KingMed.info
340
Desai R., Eddings W., Liao K. et al. Disease-modifying antirheumatic drug use and the risk of incident
hyperlipidemia in patients with early rheumatoid arthritis: aretro-spective cohort study // Arthritis Care
Res. 2015. Vol. 67. P. 457-466.
Dhital R., Basnet S., Poudel D.R. Impact of hypothyroidism on occurrence and outcome of acute
coronary syndrome from the National Inpatient Sample // Am. J.
Cardiol. 2017. Vol. 120, N. 12. P. 2160-2163.
Dimitriadis G., Papadopoulos V., Mimidis K. Eplerenone reverses spironolac-tone-induced painful
gynaecomastia in cirrhotics // Hepatol. Int. 2011. Vol. 5, N. 2.
P. 738-739.
Direkvand-Moghadam A., Jaafarpour M., Khani A. et al. The effect of oral pro-pranolol plus oxytocin
versus oxytocin only on the process and outcome of labor: a double-blind randomized trial // Iran J.
Nurs. Midwifery Res. 2014. Vol. 19, N. 5.
P. 491-495.
Dixon W., Suissa S., Hudson M. et al. The association between systemic glucocorticoid therapy and the
risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses // Arthritis
Res. Ther. 2011. Vol. 4. P. R139.
Djulus J, Koren G, Einarson TR, et al. Exposure to mirtazapine during pregnancy: a prospective,
comparative study ofbirth outcomes. J Clin Psychiatry. 2006;67(8):1280-4.
Dobrzycki S, Baniukiewicz A, Korecki J, et al. Does gastro-esophageal reflux provoke the myocardial
ischemia in patients with CAD? Int J Cardiol. 2005;104(1):67-72.
Dong Y.H., Lin H.H., Shau W.Y. et al. Comparative safety of inhaled medications in patients with chronic
obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of
randomised controlled trials // Thorax. 2013.
Vol. 68, N. 1. P. 48-45.
Dormuth C.R., Carney G., Carleton B. et al. Thiazolidinediones and fractures in
men and women // Arch. Intern. Med. 2009. Vol. 169, N. 15. P. 1395-1402.
Dormuth C.R., Hemmelgarn B.R., Patersonsor J.M. et al. Use of high potency statins and rates of
admission for acute kidney injury: multicenter, retrospective observational analysis of administrative
databases // BMJ. 2013. Vol. 346. Article ID f880.
Douglas I.J., Langham J., Bhaskaran K. et al. Orlistat and the risk of acute liver injury: self-controlled case
series study in UK Clinical Practice Research Datalink //
BMJ. 2013. Vol. 346. Article ID f1936.
Doumas M., Douma S. The effect of antihypertensive drugs on erectile function: aproposed
management algorithm // J. Clin. Hypertens. 2006. Vol. 8. P. 359-363.
Doumas M., Tsakiris A., Douma S. et al. Beneficial effects of switching from beta-blockersto nebivolol
on the erectile function of hypertensive patients // Asian J. Androl.
2006. Vol. 8. P. 177-182.
Соседние файлы в папке Библиотека им академика М.И. Перельмана